Variant report

Variant	nsv544087
Chromosome Location	chr19:56257156-56489029
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:975)
CpG islands
(count:2444)
Chromatin interactive
region (count:32)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:975 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr19:56320785-56321060	GM12878	blood:	n/a	n/a
2	ATF3	chr19:56320795-56321061	K562	blood:	n/a	n/a
3	BATF	chr19:56404597-56404754	GM12878	blood:	n/a	n/a
4	BCL11A	chr19:56404582-56404766	GM12878	blood:	n/a	n/a
5	BCL11A	chr19:56404601-56404738	GM12878	blood:	n/a	n/a
6	BHLHE40	chr19:56320723-56321185	K562	blood:	n/a	n/a
7	BHLHE40	chr19:56320784-56321089	HepG2	liver:	n/a	n/a
8	CBX3	chr19:56347744-56348093	K562	blood:	n/a	n/a
9	CBX3	chr19:56485399-56485613	K562	blood:	n/a	n/a
10	CBX3	chr19:56320575-56321158	K562	blood:	n/a	n/a
11	CBX3	chr19:56320742-56321100	K562	blood:	n/a	n/a
12	CEBPB	chr19:56413977-56414273	K562	blood:	n/a	chr19:56414104-56414121 chr19:56414107-56414118 chr19:56414109-56414120 chr19:56414107-56414120 chr19:56414107-56414120
13	CEBPB	chr19:56342021-56342353	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr19:56342129-56342342	K562	blood:	n/a	n/a
15	CEBPB	chr19:56258745-56258858	HepG2	liver:	n/a	chr19:56258809-56258820
16	CEBPB	chr19:56277973-56278182	K562	blood:	n/a	chr19:56278128-56278141
17	CEBPB	chr19:56385000-56385192	K562	blood:	n/a	n/a
18	CEBPB	chr19:56268125-56268161	Hela-S3	cervix:	n/a	chr19:56268130-56268143
19	CEBPB	chr19:56448063-56448170	A549	lung:	n/a	n/a
20	CEBPB	chr19:56309941-56309963	HepG2	liver:	n/a	chr19:56309945-56309956
21	CEBPB	chr19:56268023-56268280	A549	lung:	n/a	chr19:56268130-56268143
22	CEBPB	chr19:56469909-56469933	HepG2	liver:	n/a	n/a
23	CEBPB	chr19:56341826-56342415	HCT-116	colon:	n/a	n/a
24	CEBPB	chr19:56413999-56414214	HepG2	liver:	n/a	chr19:56414104-56414121 chr19:56414107-56414118 chr19:56414109-56414120 chr19:56414107-56414120 chr19:56414107-56414120
25	CEBPB	chr19:56341872-56342423	HCT-116	colon:	n/a	n/a
26	CEBPB	chr19:56342114-56342249	K562	blood:	n/a	n/a
27	CEBPB	chr19:56469812-56470113	MCF-7	breast:	n/a	n/a
28	CEBPB	chr19:56313719-56313987	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr19:56448058-56448093	H1-hESC	embryonic stem cell:	n/a	n/a
30	CEBPB	chr19:56480616-56480742	HepG2	liver:	n/a	chr19:56480657-56480668
31	CEBPB	chr19:56267971-56268186	K562	blood:	n/a	chr19:56268130-56268143
32	CEBPB	chr19:56306047-56306327	HepG2	liver:	n/a	chr19:56306161-56306174 chr19:56306161-56306172
33	CEBPB	chr19:56320804-56321149	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr19:56303101-56303314	HepG2	liver:	n/a	chr19:56303175-56303186 chr19:56303172-56303189
35	CEBPB	chr19:56306160-56306187	Hela-S3	cervix:	n/a	chr19:56306161-56306174 chr19:56306161-56306172
36	CEBPB	chr19:56342078-56342348	HepG2	liver:	n/a	n/a
37	CEBPB	chr19:56303142-56303233	A549	lung:	n/a	chr19:56303175-56303186 chr19:56303172-56303189
38	CEBPB	chr19:56303064-56303264	K562	blood:	n/a	chr19:56303175-56303186 chr19:56303172-56303189
39	CEBPB	chr19:56448047-56448229	IMR90	lung:	n/a	n/a
40	CEBPB	chr19:56448024-56448130	K562	blood:	n/a	n/a
41	CEBPB	chr19:56406673-56406772	HepG2	liver:	n/a	chr19:56406697-56406708
42	CEBPB	chr19:56344099-56344348	A549	lung:	n/a	n/a
43	CEBPB	chr19:56384985-56385182	HepG2	liver:	n/a	n/a
44	CREB1	chr19:56410261-56410516	A549	lung:	n/a	n/a
45	CREB1	chr19:56368555-56368853	GM12878	blood:	n/a	n/a
46	CREB1	chr19:56320773-56321071	A549	lung:	n/a	n/a
47	CTCF	chr19:56289000-56289150	HepG2	liver:	n/a	chr19:56289124-56289137 chr19:56289121-56289139
48	CTCF	chr19:56320920-56321070	HMF	breast:	n/a	n/a
49	CTCF	chr19:56295051-56295106	GM13976	blood:	n/a	n/a
50	CTCF	chr19:56425140-56425290	GM12874	blood:	n/a	chr19:56425239-56425257 chr19:56425242-56425255

(count:2444 , 50 per page) page: 1 2 3 4 5 6 7 ... 49

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:56342665-56342715	HUVEC	blood vessel:	n/a
2	chr19:56347927-56347977	SKMC	muscle:	n/a
3	chr19:56269246-56269296	LNCaP	prostate:	n/a
4	chr19:56443824-56443874	HIPEpiC	eye:	n/a
5	chr19:56342665-56342715	HUVEC	blood vessel:	n/a
6	chr19:56347927-56347977	SKMC	muscle:	n/a
7	chr19:56269246-56269296	LNCaP	prostate:	n/a
8	chr19:56443824-56443874	HIPEpiC	eye:	n/a
9	chr19:56443419-56443469	A549	lung:	n/a
10	chr19:56274428-56274478	AG09309	skin:	n/a
11	chr19:56348742-56348792	BJ	skin:	n/a
12	chr19:56363105-56363155	HIPEpiC	eye:	n/a
13	chr19:56369416-56369466	HCT-116	colon:	n/a
14	chr19:56369416-56369466	HRCEpiC	kidney:	n/a
15	chr19:56347847-56347897	PFSK-1	brain:	n/a
16	chr19:56369416-56369466	HPAEpiC	pulmonary alveolar:	n/a
17	chr19:56361716-56361766	ECC-1	luminal epithelium:	n/a
18	chr19:56466500-56466550	AG04449	skin:	fetal
19	chr19:56393163-56393213	BE2_C	brain:	n/a
20	chr19:56363105-56363155	HRPEpiC	eye:	n/a
21	chr19:56269259-56269309	AG09319	gingival:	n/a
22	chr19:56346743-56346793	HL-60	blood:	n/a
23	chr19:56321115-56321165	PrEC	prostate:	n/a
24	chr19:56367830-56367880	AG10803	skin:	n/a
25	chr19:56347771-56347821	HAEpiC	amniotic membrane:	n/a
26	chr19:56444551-56444601	U87	brain:	n/a
27	chr19:56274428-56274478	BE2_C	brain:	n/a
28	chr19:56347722-56347772	AG04449	skin:	fetal
29	chr19:56347870-56347920	SK-N-MC	brain:	n/a
30	chr19:56418660-56418710	GM12878	blood:	n/a
31	chr19:56363105-56363155	HepG2	liver:	n/a
32	chr19:56443419-56443469	Jurkat	blood:	n/a
33	chr19:56348742-56348792	A549	lung:	n/a
34	chr19:56321115-56321165	HL-60	blood:	n/a
35	chr19:56364183-56364233	HEEpiC	esophagus:	n/a
36	chr19:56270729-56270779	H1-hESC	embryonic stem cell:	embryo
37	chr19:56444163-56444213	AG04450	lung:	fetal
38	chr19:56270498-56270548	GM12891	blood:	n/a
39	chr19:56348216-56348266	SK-N-SH_RA	brain:	n/a
40	chr19:56274428-56274478	GM19239	blood:	n/a
41	chr19:56270498-56270548	NH-A	brain:	n/a
42	chr19:56369522-56369572	HRCEpiC	kidney:	n/a
43	chr19:56418660-56418710	PrEC	prostate:	n/a
44	chr19:56444551-56444601	MCF10A-Er-Src	breast:	n/a
45	chr19:56443824-56443874	GM12878	blood:	n/a
46	chr19:56274428-56274478	NT2-D1	testis:	n/a
47	chr19:56444551-56444601	HCF	heart:	n/a
48	chr19:56347870-56347920	K562	blood:	n/a
49	chr19:56466500-56466550	Jurkat	blood:	n/a
50	chr19:56347771-56347821	PrEC	prostate:	n/a

(count:32 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:41464575..41466240-chr19:56288867..56290367,2	K562	blood:
2	chr19:56437345..56439386-chr19:56452694..56454259,2	K562	blood:
3	chr19:56271991..56273573-chr19:56281048..56283702,2	K562	blood:
4	chr19:56321292..56324216-chr19:56328648..56330959,2	K562	blood:
5	chr19:56288962..56289563-chr19:56320651..56321410,3	MCF-7	breast:
6	chr19:56154646..56157469-chr19:56320244..56322064,2	K562	blood:
7	chr19:56311206..56314019-chr19:56318458..56321376,2	K562	blood:
8	chr19:56464653..56466307-chr19:56469683..56471185,2	K562	blood:
9	chr19:56439351..56441429-chr19:56446067..56448328,2	MCF-7	breast:
10	chr19:56327095..56328748-chr19:56329446..56331884,2	K562	blood:
11	chr19:56464653..56466307-chr19:56469683..56471185,2	K562	blood:
12	chr19:56015535..56016051-chr19:56320998..56321733,2	K562	blood:
13	chr19:56164701..56165323-chr19:56320540..56321426,2	MCF-7	breast:
14	chr19:56294175..56296046-chr19:56307232..56309273,2	MCF-7	breast:
15	chr19:56294175..56296046-chr19:56307232..56309273,2	MCF-7	breast:
16	chr19:56320256..56321150-chr19:56577550..56578288,2	K562	blood:
17	chr19:56271991..56273573-chr19:56281048..56283702,2	K562	blood:
18	chr19:56439351..56441429-chr19:56446067..56448328,2	MCF-7	breast:
19	chr19:56373661..56375169-chr19:56376696..56378685,2	K562	blood:
20	chr19:56464807..56467455-chr19:56469685..56471686,2	K562	blood:
21	chr19:56373661..56375169-chr19:56376696..56378685,2	K562	blood:
22	chr19:56424869..56425718-chr19:56582163..56583125,2	MCF-7	breast:
23	chr19:56311206..56314019-chr19:56318458..56321376,2	K562	blood:
24	chr19:56464807..56467455-chr19:56469685..56471686,2	K562	blood:
25	chr19:56430402..56432379-chr19:56447676..56449907,2	K562	blood:
26	chr19:56230205..56232527-chr19:56319829..56322446,2	K562	blood:
27	chr19:56252523..56255492-chr19:56257324..56260762,3	K562	blood:
28	chr19:56288962..56289563-chr19:56320651..56321410,3	MCF-7	breast:
29	chr19:56437345..56439386-chr19:56452694..56454259,2	K562	blood:
30	chr19:56454965..56456732-chr19:56458857..56460406,2	MCF-7	breast:
31	chr19:56430402..56432379-chr19:56447676..56449907,2	K562	blood:
32	chr19:56143497..56144412-chr19:56320540..56321434,5	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NLRP4-1	chr19:56399226-56399347	XLOC_013162
2	lnc-NLRP4-1	chr19:56400283-56401109	XLOC_013162

No data

Variant related genes	Relation type
NLRP13	TF binding region
RFPL4AL1	TF binding region
RFPL4AP1	TF binding region
NLRP11	TF binding region
NLRP4	TF binding region
RFPL4A	TF binding region
NLRP8	TF binding region
NLRP13	CpG island
RFPL4AL1	CpG island
RFPL4AP1	CpG island
NLRP11	CpG island
NLRP4	CpG island
RFPL4A	CpG island
NLRP8	CpG island
ENSG00000179873	chromatin interactions
ENSG00000267522	chromatin interactions
ENSG00000188825	chromatin interactions
ENSG00000179709	chromatin interactions
ENSG00000171425	chromatin interactions

Extended variants
information (count: 3846 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:3846 , 50 per page) page: 1 2 3 4 5 6 7 ... 77

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10416184	chr19:56264402-56264403	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs112914242	chr19:56264415-56264416	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs577447921	chr19:56264429-56264430	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs534648424	chr19:56264459-56264460	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs557885908	chr19:56264461-56264462	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs567697651	chr19:56264462-56264463	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs141201281	chr19:56264479-56264480	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs10416393	chr19:56264491-56264492	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs574171460	chr19:56264505-56264506	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs12973665	chr19:56264521-56264522	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs111910789	chr19:56264535-56264536	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs147331682	chr19:56264546-56264547	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs545046862	chr19:56264623-56264624	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs565145396	chr19:56264651-56264652	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs139324971	chr19:56264653-56264654	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs374025077	chr19:56264663-56264664	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs184924614	chr19:56264695-56264696	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs529138402	chr19:56264697-56264698	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs538627791	chr19:56264716-56264717	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs377731929	chr19:56264744-56264745	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs74419760	chr19:56264811-56264812	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs34837325	chr19:56264818-56264819	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs386389299	chr19:56264833-56264834	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs376868498	chr19:56264834-56264835	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs546125296	chr19:56264836-56264837	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs369229271	chr19:56264837-56264838	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs57710529	chr19:56264849-56264850	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs74179636	chr19:56264850-56264851	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs143044120	chr19:56264869-56264870	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs73933326	chr19:56264884-56264885	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs144677097	chr19:56264977-56264978	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs115133371	chr19:56264983-56264984	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs111482761	chr19:56265013-56265014	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs189778113	chr19:56265074-56265075	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs34047470	chr19:56265091-56265092	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs537119347	chr19:56265096-56265097	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs556806436	chr19:56265120-56265121	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs73055904	chr19:56265121-56265122	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs536488226	chr19:56265132-56265133	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs371149632	chr19:56265144-56265145	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs553248027	chr19:56265165-56265166	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs376628600	chr19:56265169-56265170	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs12460887	chr19:56265195-56265196	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs533568271	chr19:56265203-56265204	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs182434812	chr19:56265204-56265205	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs148496136	chr19:56265205-56265206	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs554064513	chr19:56265206-56265207	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs558884325	chr19:56265217-56265218	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs575578302	chr19:56265277-56265278	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs142876336	chr19:56265373-56265374	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Breast cancer	20459607	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Alzheimer''s disease	22166940	CNVD
Heart disease	21282601	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Glioblastoma multiforme	21922591	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Melanoma	20877625	CNVD
Breast cancer	20409316	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:106 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:56264400-56265000	Enhancers	Liver	Liver
2	chr19:56264800-56265600	Enhancers	Rectal Mucosa Donor 31	rectum
3	chr19:56265000-56265400	Flanking Active TSS	Liver	Liver
4	chr19:56265000-56266000	Enhancers	Pancreas	Pancrea
5	chr19:56265400-56265600	Enhancers	Liver	Liver
6	chr19:56265400-56265800	Enhancers	Gastric	stomach
7	chr19:56265600-56265800	Flanking Active TSS	Liver	Liver
8	chr19:56265800-56268200	Weak transcription	Liver	Liver
9	chr19:56266000-56266800	Weak transcription	Pancreas	Pancrea
10	chr19:56266800-56267000	Enhancers	Pancreas	Pancrea
11	chr19:56267000-56268200	Weak transcription	Pancreas	Pancrea
12	chr19:56268000-56269800	Enhancers	Primary monocytes fromperipheralblood	blood
13	chr19:56268200-56268400	ZNF genes & repeats	Liver	Liver
14	chr19:56268200-56268400	Enhancers	Pancreas	Pancrea
15	chr19:56268400-56272600	Weak transcription	Liver	Liver
16	chr19:56269800-56270200	Weak transcription	Primary monocytes fromperipheralblood	blood
17	chr19:56270200-56271800	Enhancers	Primary monocytes fromperipheralblood	blood
18	chr19:56272600-56272800	Active TSS	Liver	Liver
19	chr19:56277000-56279600	Enhancers	Primary monocytes fromperipheralblood	blood
20	chr19:56278000-56278200	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
21	chr19:56279600-56280000	Weak transcription	Primary monocytes fromperipheralblood	blood
22	chr19:56280000-56281800	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr19:56281200-56281800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr19:56293200-56293400	Enhancers	Hela-S3	cervix
25	chr19:56295400-56295600	ZNF genes & repeats	iPS-15b Cell Line	embryonic stem cell
26	chr19:56300600-56304000	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr19:56306200-56310800	Weak transcription	Pancreas	Pancrea
28	chr19:56307400-56313400	Weak transcription	Liver	Liver
29	chr19:56312000-56313000	Enhancers	GM12878-XiMat	blood
30	chr19:56312800-56313200	Active TSS	Brain Substantia Nigra	brain
31	chr19:56312800-56313400	Enhancers	Primary B cells from peripheral blood	blood
32	chr19:56313000-56313400	Flanking Active TSS	GM12878-XiMat	blood
33	chr19:56313000-56313400	Enhancers	Hela-S3	cervix
34	chr19:56313200-56315600	Weak transcription	Brain Substantia Nigra	brain
35	chr19:56313400-56314200	Enhancers	Liver	Liver
36	chr19:56313800-56314000	Enhancers	Hela-S3	cervix
37	chr19:56315600-56316000	ZNF genes & repeats	iPS-20b Cell Line	embryonic stem cell
38	chr19:56315600-56316200	ZNF genes & repeats	Brain Substantia Nigra	brain
39	chr19:56316200-56320800	Weak transcription	Brain Substantia Nigra	brain
40	chr19:56318800-56319800	Weak transcription	Liver	Liver
41	chr19:56319800-56320600	Enhancers	Liver	Liver
42	chr19:56320200-56321000	ZNF genes & repeats	HUES6 Cell Line	embryonic stem cell
43	chr19:56320400-56320600	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr19:56320400-56321000	ZNF genes & repeats	A549	lung
45	chr19:56320400-56321200	Enhancers	GM12878-XiMat	blood
46	chr19:56320600-56320800	Active TSS	Adipose Nuclei	Adipose
47	chr19:56320600-56320800	Flanking Active TSS	Hela-S3	cervix
48	chr19:56320600-56321000	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
49	chr19:56320600-56321000	Flanking Active TSS	Liver	Liver
50	chr19:56320600-56321000	Active TSS	Duodenum Mucosa	Duodenum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links